Loading...
XNAS
CELZ
Market cap6mUSD
Dec 05, Last price  
2.34USD
1D
5.41%
1Q
-29.31%
IPO
20,247.83%
Name

Creative Medical Technology Holdings Inc

Chart & Performance

D1W1MN
XNAS:CELZ chart
P/E
P/S
548.98
EPS
Div Yield, %
Shrs. gr., 5y
310.81%
Rev. gr., 5y
-41.85%
Revenues
11k
+22.22%
000000000004,800124,400165,500164,50087,75488,6009,00011,000
Net income
-5m
L+3.91%
1,372-9,544-52,636-31,610-17,256-24,055-25,585-27,282-28,012-30,761-766,072-2,659,108-13,655,653-10,379,201-37,554,82014,933,335-10,043,716-5,286,574-5,493,481
CFO
-5m
L-33.96%
1,139-12,857-57,164-30,742-13,661-13,959-16,774-22,907-17,320-14,638-445,232-889,621-1,052,270-1,213,093-434,556-2,215,782-7,796,966-8,027,884-5,301,292

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
IPO date
May 01, 2009
Employees
4
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT